Stay updated on Selpercatinib in RET-Mutant Medullary Thyroid Cancer Clinical Trial

Sign up to get notified when there's something new on the Selpercatinib in RET-Mutant Medullary Thyroid Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Selpercatinib in RET-Mutant Medullary Thyroid Cancer Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The Veneto, Italy site listing changed from Padua to Padova (postal code 35128).
    Difference
    0.0%
    Check dated 2026-04-06T03:10:48.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    A new publication citation has been added to the Publications section: 'Assessing side-effect bother, burden, and tolerability: A qualitative study exploring the content validity of the Functional Assessment of Cancer Therapy - Item GP5.' This reference provides additional context for the study's reported outcomes but does not modify study design or participant information.
    Difference
    0.0%
    Check dated 2026-03-30T01:57:07.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    Napoli, Campania, Italy, 80131 was renamed to Naples, Campania, Italy, 80131 and a Naples listing was added, with the page revision updated to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-22T21:21:45.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    Added Revision: v3.4.3; removed Revision: v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-08T04:41:08.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.1 to v3.4.2. This appears to be a version control update with no visible changes to study information or page layout.
    Difference
    0.0%
    Check dated 2026-02-14T13:14:56.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1. This appears to be a minor technical update without changes to the study content or user-facing features.
    Difference
    0.0%
    Check dated 2026-02-07T07:42:16.000Z thumbnail image

Stay in the know with updates to Selpercatinib in RET-Mutant Medullary Thyroid Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Selpercatinib in RET-Mutant Medullary Thyroid Cancer Clinical Trial page.